biOasis Technologies Inc. is a ground-breaking biopharmaceutical company focused on the delivery of therapeutics across the blood-brain barrier (BBB) and into the brain tissue. The delivery of therapeutics across the BBB represents the single greatest challenge in the treatment of over a thousand common and rare diseases of the central nervous system. Fewer than 2% of medications are able to cross the BBB making this a large obstacle in patient treatment for brain diseases that affect 1 and 6 people worldwide.


Visit bctech for more information about BiOasis Technologies.